Lv1
60 积分 2024-03-18 加入
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer
3天前
已完结
Validation of a nomogram for selecting patients for chemotherapy after D2 gastrectomy for cancer
1个月前
已完结
Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma
1个月前
已完结
Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent
1个月前
已完结
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials
1个月前
已完结
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
1个月前
已完结
Interleukin (IL)-17 Versus IL-23 Inhibitors: Which Is Better to Treat Patients With Moderate-to-Severe Psoriasis and Mild Psoriatic Arthritis in Dermatology Clinics?
1个月前
已完结
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
2个月前
已完结
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
2个月前
已完结
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results
2个月前
已完结
皖公网安备34019202002308
